VeinWay’s CEO: “This is a pivotal year for us”. An interview with Venous News.

With seven compassionate-use cases under its belt and commercialization in view, VeinWay—developer of the Traversa, a tool for crossing tough venous occlusions—is at a crucial point in its evolution. That is according to chief executive officer (CEO) and co-founder Jordan Pollack, who recently spoke with Venous News about the company’s short- and longer-term goals. He anticipates some challenges in the years ahead, especially with regard to fundraising, and underlines the importance of there being venous-dedicated companies for venous-specific innovation in this often “neglected” space.

What’s in store for VeinWay in the second half of 2024?